Nuts, Just a thought. If PRR has global manufacturing facilities for CVac could it not then licence out the trial and delivery side for other cancers to other Pharmas with Prima Biomed to receive goodwill payments and royalties in those cases. Is this possibly far fetched on my part.
Also I interpret the early move to other cancers with potentially massive markets, am I being too presumptuous in believing they must be really confident that the ovarian cancer trial will be successful? Am I missing something here?
Given Marc Voigt is based in Germany is this where the action with other Pharmas likely to come from? It was Germany that provided Prima with a $5mill grant.
cheers
- Forums
- ASX - By Stock
- big phamas and more mentioned at agm
Nuts, Just a thought. If PRR has global manufacturing facilities...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
29.5¢ |
Change
0.005(1.72%) |
Mkt cap ! $428.5M |
Open | High | Low | Value | Volume |
29.0¢ | 29.8¢ | 29.0¢ | $539.5K | 1.834M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 214062 | 29.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.5¢ | 469318 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
15 | 214062 | 0.290 |
19 | 266746 | 0.285 |
19 | 557602 | 0.280 |
6 | 224918 | 0.275 |
9 | 226781 | 0.270 |
Price($) | Vol. | No. |
---|---|---|
0.295 | 469318 | 5 |
0.300 | 654947 | 7 |
0.305 | 155034 | 7 |
0.310 | 502791 | 5 |
0.315 | 142694 | 7 |
Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |